A land-owning class, the Jats are a powerful community and account for 28 per cent of Haryana's population. The time, they believe, has now come for them to take revenge. IMAGE: Congress leader......
IMAGE: Kindly note the image has been posted only for representational purposes. Photograph: Kind courtesy Castorly Stock/Pexels.com and Pixabay.com The top 300 pharmaceutical brands in the......
According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a......
Sources indicated that as there were no fresh orders from the Government of India, their supply commitments have ended as of March 31, reports Sohini Das. IMAGE: Vials of Covishield vaccine.......
The first indigenous vaccine against pneumonia, developed by Serum Institute of India (SII), is slated to be launched by Union Health Minister Harsh Vardhan and made available in the domestic......
India has not accepted the demand of the UK for inclusion of a 'data exclusivity' provision in the free trade agreement, announced on May 6, in a bid to protect the interests of the domestic......
GlaxoSmithKline Pharmaceuticals Limited is expanding its clinical trial data management, analyses and reporting activities in India where it plans to double the headcount depending on business......
GlaxoSmithKline Pharmaceuticals Ltd is planning to in-licence the blockbuster cardiovascular drug, Carvedilol, of Swiss pharmaceuticals major Roche for the Indian market.Carvedilol is the first......
Deviating from the global business strategy of its UK parent, GlaxoSmithKline Pharmaceuticals India, the largest multinational drugs company in the country, is planning to sell in India drugs that......
Nicholas Piramal India, one of the leading pharmaceutical companies, is likely to sign a third party manufacturing contract with the global pharmaceutical leader GlaxoSmithKline for its avian flu......
While it is difficult to put a number on how much the impact on the ad sales tally could be, it is quite possible the broadcaster will not be able to make its Rs 2-billion target, says Urvi......